Identification
Instrument name
GENTICEL
Symbol
GTCL
ISIN code
FR0011790542
Exchange / Market
Euronext
Trading location
Brussels
Paris
Products family
Stocks
Capitalization compartment
Compartment C
ICB
Biotechnology
Activity description

<p>
Genticel specializes in developing therapeutic vaccines for the prevention of the cancer of the cervix in women infected by the human papillomavirus (HPV).<br />
<em>Source: Cofisem</em></p>

Operation
IPO date
IPO type

<p>
Initial Public Offering</p>

IPO price
EUR 7.90
IPO type
Initial Public offering
Catégorie
IPO
Price range
EUR 6,75 - EUR 8,25
Capital raised
34.5